Leading the way in population health

Invitae’s population health program is a comprehensive, customizable, robust end-to-end solution for your community.

Get Started

Leading the way in population health

Invitae’s population health program is a comprehensive, customizable, robust end-to-end solution for your community.

Get Started

Our health is in our genes


The role that genetics plays in our health and wellbeing is becoming more apparent every year. 

With the insight provided by genetic testing, participants are able to work with their doctors to make proactive and informed health decisions.


Cancer and heart disease are the leading causes of death for Americans.

We now know that many who are diagnosed were genetically predisposed to developing these conditions.

Even for adults who are currently healthy, knowing their genetic risk of developing a disease can be empowering.

As with any disease, early detection and intervention is key to reducing morbidity and mortality.

Impacting healthcare through genomics

As the cost of DNA sequencing continues to decrease, the benefit of genetic testing increases.

As a result, more people are making genetic testing a central part of their healthcare process.

Invitae gene panels

Invitae offers clinical-quality gene panels for 
CDC Tier 1 applications to detect the genetic risk for hereditary breast and ovarian cancer (HBOC), Lynch syndrome, and familial hypercholesterolemia.

Additional panels are also available and can be tailored to the needs of a population health program.

Benefits of Invitae’s population health program

Lower healthcare costs

A proactive approach to healthcare today could offer savings on costly treatments in the future.

Increased engagement

Through regular check-ups and screenings, participants can protect their long-term health by establishing a personalized care plan with their doctor.

Flexible and scalable

Every community has its own needs. Invitae can tailor a population health program to fit the unique needs of an initiative to ensure it achieves success.

Invitae is there every step of the way

1) Awareness:

Through educational videos, print materials, tailored on-site visits, and community engagement initiatives, Invitae can work with you to inform your community and clinicians about the benefits of genetic testing. Participants may also learn about the importance of testing for at-risk family members.

2) Ordering:

Invitae makes it easy to order genetic testing for your community, with multiple workflow options designed to fit the needs of a population health program.

3) Results:

Participants receive easy to understand results they can bring to their doctor to create a personalized health management program.

4) Counseling:

Invitae’s board-certified genetic counselors are available on-demand to answer both participant and clinician questions. Participants are also able to schedule a personalized session to speak with a genetic counselor about their results and the appropriate next steps. 

Genetic information for a healthier community


Invitae is a leading genetics company whose mission is to change healthcare by making genetic information affordable and accessible to everyone in the world. 

  • Our team brings together leading experts in genetics and healthcare.

  • Our clinical-quality genetic tests for population health initiatives are the same tests that are used by doctors and genetic counselors.

  • Our industry-leading lab is equipped with highly advanced technology that delivers accurate and reliable information.

  • Our lab meets or exceeds all CLIA and CAP standards.

We believe that genetic information can save lives. That's why in 2016 we were one of the first genetics companies to offer testing for healthy individuals—enabling them to take steps to prevent or treat medical conditions before getting sick.


The public and genetic editing, testing, and therapy. Harvard T.H. Chan School of Public Health. https://cdn1.sph.harvard.edu/wp-content/uploads/sites/94/2016/01/STAT-Harvard-Poll-Jan-2016-Genetic-Technology.pdf. Published January 2016. Accessed January 2020.